This inverse relationship between SHBG and insulin is particularly pronounced among women with greater liver fat accumulation (62, 70), suggesting a compounded metabolic risk in the presence of both hepatic steatosis and decreased SHBG. This evidence concerns the gene INS and fatty liver disease.